Search Results
Search for other papers by P. Løvendahl in
Google Scholar
PubMed
Search for other papers by K. D. Angus in
Google Scholar
PubMed
Search for other papers by J. A. Woolliams in
Google Scholar
PubMed
ABSTRACT
Eighty 4-month-old calves of both sexes and of two selected lines differing by 70 kg in their predicted total yield of milk fat and protein were injected intravenously with three of four GH secretagogues: these were, per kg liveweight; (i) 0·2 μg human GH-releasing factor(1–29) (GRF), (ii) 0·2 μg TRH, (iii) a combination of (i) and (ii), and (iv) 0·1 g arginine hydrochloride. The response of GH was measured for 2 h following administration. Geometric mean concentration of the 5-, 10-, 15- and 20-min samples following GRF, TRH and their combination were 29·3, 19·5 and 156 μg/l compared with baseline means of 6·5, 10·0 and 12·6 μg/l respectively, and for arginine (in which the mean response included the 30-min instead of the 5-min sample) 14·6 μg/l compared with a baseline of 8·31 μg/l. The line selected for greater yield responded more to each secretagogue by 1·53-fold following GRF (P < 0·01), 1·34-fold following TRH (P < 0·05), 1·11-fold following the combination (P > 0·01) and 1·26-fold following arginine (P < 0·1). Females responded 2·3-fold more than males following GRF administration (P < 0·001), only 1·2-fold more following TRH (P > 0·1), but less (0·63-fold) than males when GRF was combined with TRH (P < 0·05). For all secretagogues the concentration of GH before administration was important in determining the size of response (P < 0·001). It was concluded that the increased release of GH following the administration of GRF and TRH was a direct result of selection for dairy merit and that increased yields during lactation may, in part, be mediated directly through pituitary responsiveness.
Journal of Endocrinology (1991) 128, 419–424
Search for other papers by R. W. Lea in
Google Scholar
PubMed
Search for other papers by C. A. Ahene in
Google Scholar
PubMed
Search for other papers by J. A. Marsh in
Google Scholar
PubMed
Search for other papers by S. Harvey in
Google Scholar
PubMed
ABSTRACT
The i.c.v. administration of 0·1 or 10 μg ovine (o)GH to 12- to 16-week-old hypothyroid chickens of a sex-linked dwarf (SLD) strain suppressed the basal plasma GH concentrations, measured 24 h afterwards. The GH response of the oGH-injected SLDs to TRH was suppressed, in a dose-related way, in comparison with that induced by TRH in birds given control injections (10 μg) of bovine serum albumin (BSA). Basal circulating concentrations of GH in euthyroid K strain birds of the same age were even lower than in the SLDs following injection of 10 μg oGH, and were not further reduced by oGH administration. The GH response to TRH in the K strain birds injected i.c.v. with 0·1 or 10 μg oGH was, nevertheless, suppressed in comparison with the BSA-injected K strain controls. The i.c.v. administration of oGH also suppressed circulating concentrations of LH and the LH response to TRH in the K strain birds.
Twenty-four hours after i.c.v. administration of oGH (10 μg), the somatostatin (SRIF) content in the medial basal hypothalamus of 8-week-old euthyroid cockerels was greater than that in BSA (10 μg)-injected controls. At the same time, the binding of [3H]3-methyl-histidine2-TRH to the pituitary caudal and cephalic lobes of GH-injected birds was less than that in the controls.
These results suggest that GH regulation in avian species is partly mediated by an inhibitory short-loop mechanism (mediated by hypothalamic SRIF and a down-regulation of pituitary TRH-binding sites) that suppresses basal and secretagogue-induced GH release.
Journal of Endocrinology (1990) 126, 237–244
Search for other papers by R. Peeters in
Google Scholar
PubMed
Search for other papers by N. Buys in
Google Scholar
PubMed
Search for other papers by D. Vanmontfort in
Google Scholar
PubMed
Search for other papers by J. Van Isterdael in
Google Scholar
PubMed
Search for other papers by E. Decuypere in
Google Scholar
PubMed
Search for other papers by E. R. Kühn in
Google Scholar
PubMed
ABSTRACT
The influence of TRH and TSH injections on plasma concentrations of tri-iodothyronine (T3) and thyroxine (T4) was investigated in neonatal (injection within 0·5 h after delivery) and growing lambs and in normal, pregnant and lactating adult ewes (all 2 years old and originating from Suffolk, Milksheep and Texal cross-breeds). Neonatal lambs had higher levels of T3, T4 and GH compared with all other groups, whereas prolactin and TSH were higher in lactating ewes. In all animals, injections of TRH increased plasma concentrations of prolactin and TSH after 15 min but not of GH at any time. Small increases in T3 and T4 were observed in neonatal lambs, without any effect on the T3 and T4 ratio, after prolactin administration, whereas prolactin did not influence plasma concentrations of T3 or T4 in all other experimental groups. Similar results for thyroid hormones were obtained after TRH or TSH injections. It was therefore concluded that the effects observed after TRH challenge were mediated by the release of TSH. With the possible exception of neonatal lambs, plasma concentrations of T3 after administration of TRH or TSH were always increased before those of T4; the increase in T3 occurred within 0·5–1 h compared with 2–4 h for T4 in all experimental groups. This resulted in an increased ratio of plasma T3 to T4 up to 4 h after injection. It is concluded that, in sheep, TRH and TSH preferentially release T3 from the thyroid gland probably by a stimulatory effect of TSH on the intrathyroidal conversion of T3 to T4.
Journal of Endocrinology (1992) 132, 93–100
Search for other papers by S. Franks in
Google Scholar
PubMed
Search for other papers by H. D. Mason in
Google Scholar
PubMed
Search for other papers by K. I. J. Shennan in
Google Scholar
PubMed
Search for other papers by M. C. Sheppard in
Google Scholar
PubMed
ABSTRACT
We have studied the effect of oestradiol (OE2) on secretion of prolactin and TSH by rat pituitary glands and correlated this with changes in hypothalamic content and release of thyrotrophin-releasing hormone (TRH). Ovariectomized Wistar rats received s.c. silicone elastomer implants of OE2 at a dose known to give pro-oestrous OE2 levels. After 1 week rats were decapitated, blood was collected for assay of prolactin and TSH, blocks of hypothalamus were dissected out and pituitary glands were removed and bisected. Medium bathing hemipituitary glands was collected for measurement of prolactin and TSH after a 30-min incubation. Immunoreactive TRH was measured in medium removed from hypothalami and in extracts of homogenized hypothalami. Serum prolactin was higher in OE2-treated than in control animals (59·3 ± 19·5 (s.e.m.) vs 9·4 ± 1·5 μg/l; P<0·05) and this was associated with a threefold increase in pituitary prolactin in the medium. By contrast, TSH concentrations in serum and pituitary incubation medium were not significantly different in the two groups. There was no difference between the groups in hypothalamic content of TRH but TRH release in the incubation medium was increased by OE2 (30·2 ± 6·5 vs 10·0 ± 1·3 pg/mg protein per 30 min; P<0·01). In summary, physiological levels of OE2 stimulated prolactin secretion without change in TSH and this was associated with a threefold increase in hypothalamic release of TRH. These findings suggest that the stimulating effect of OE2 on prolactin secretion may, in part, be mediated by hypothalamic TRH.
J. Endocr. (1984) 103, 257–261
Search for other papers by H. J. CHEN in
Google Scholar
PubMed
Search for other papers by P. G. WALFISH in
Google Scholar
PubMed
SUMMARY
The effects of ovariectomy and ovariectomy and treatment with oestradiol benzoate (OB) on the basal concentration of thyrotrophin (TSH), the total concentrations and concentrations of free tri-iodothyronine (T3) and thyroxine (T4), and the concentrations of TSH, T3 and T4 observed after treatment with thyrotrophin releasing hormone (TRH) were studied in old (16–17 months of age) constant oestrous and young (3–4 months of age) oestrous rats. The untreated old control rats had significantly (P< 0·001) lower basal total T4 concentrations and percentage and absolute concentrations of free T4 and lower percentage and absolute concentrations of free T3 than untreated young rats. The basal levels of TSH in these two groups were similar and the increases in TSH after injection of TRH were identical. Two weeks after ovariectomy, no significant additional differences in hormone concentrations between old and young rats were observed. However, release of TSH induced by TRH was increased by three- to fourfold in old rats after ovariectomy compared with nine- to tenfold in young ovariectomized rats (P<0·01). Basal T4 concentrations remained unchanged in old ovariectomized rats treated for 7 days with 2 μg OB/day compared with both intact and ovariectomized rats. However, T4 concentrations in OB-treated young rats were significantly (P<0·001) reduced. Treatment with OB significantly increased both basal and TRH-induced T3 and TSH levels in old and young rats although the young rats showed a greater response (P<0·001). Two hours after injection of TRH, serum T3 concentrations in old rats increased only after OB treatment and not after ovariectomy alone or in intact rats, whereas T3 concentrations rose in all three groups of young animals.
These results indicate that (1) older female rats have lower total T4, free T4 and free T3 concentrations and a lower TSH response to TRH, (2) OB treatment in young rats suppresses serum T4 but increases serum T3 and results in a greater TSH response to TRH and (3) at least one of the mechanisms accounting for the alterations in thyroid function observed in the older female rat, in addition to possible concomitant primary thyroid gland hypofunction, is a hyporesponsiveness of pituitary thyrotrophs to both endogenous negative feedback signals from low serum thyroid hormone concentrations and exogenous TRH stimulation.
Search for other papers by G. B. Thomas in
Google Scholar
PubMed
Search for other papers by J. T. Cummins in
Google Scholar
PubMed
Search for other papers by J. M. Hammond in
Google Scholar
PubMed
Search for other papers by R. J. E. Horton in
Google Scholar
PubMed
Search for other papers by I. J. Clarke in
Google Scholar
PubMed
ABSTRACT
Surgical disconnection of the ovine hypothalamus from the pituitary gland (hypothalamo-pituitary disconnection; HPD) has provided a useful experimental model for studying the control of gonadotrophin secretion. The objective of the present study was to define the characteristics of prolactin secretion using stimuli acting through the hypothalamus or directly on the pituitary gland in HPD ewes. Prolactin responses to either a stressful stimulus or the dopaminergic antagonists metoclopramide (20 mg i.v.) or chlorpromazine (50 mg i.v.) seen in intact animals (sham-HPD) were completely abolished by HPD. Injection of TRH (100 μg i.v.) caused an immediate release of prolactin in both groups of ewes. In the HPD ewes plasma prolactin concentrations remained raised for at least 3 h after TRH injection, whereas in sham-HPD ewes prolactin concentrations began to decline after 20 min. Administration of bromocriptine (1 mg i.v.) 10 min after TRH inhibited the prolonged response to TRH in HPD ewes. The results support the hypothesis that prolactin exerts a short-loop feedback effect on its own secretion at the hypothalamic level.
J. Endocr. (1986) 111, 433–438
Search for other papers by G. V. Shah in
Google Scholar
PubMed
Search for other papers by R. M. Epand in
Google Scholar
PubMed
Search for other papers by R. C. Orlowski in
Google Scholar
PubMed
ABSTRACT
Salmon calcitonin inhibited TRH-stimulated release of prolactin in isolated pituitary cells from untreated female rats. These cells were still capable of responding to the fresh addition of TRH after the removal of calcitonin. Calcitonin gene-related peptide had only a weak effect in inhibiting prolactin release in these cells.
Pituitary cells isolated from female rats which had been treated with weekly s.c. injections of 1 mg oestradiol dipropionate for 4 weeks, exhibited a marked increase in the magnitude of the inhibition of prolactin release by salmon calcitonin. Both basal and TRH-stimulated release of prolactin were inhibited by concentrations of 0·1 nmol salmon calcitonin/l or higher. Prolactin release from these cells was also inhibited at somewhat higher concentrations by calcitonin gene-related peptide. Our results demonstrate that calcitonin can directly inhibit basal as well as TRH-stimulated prolactin release by acting directly at the pituitary. The results strongly suggest that the peptide may be involved in the regulation of prolactin release in certain physiological conditions.
J. Endocr. (1988) 116, 279–286
Search for other papers by N. G. Blake in
Google Scholar
PubMed
Search for other papers by M. R. Johnson in
Google Scholar
PubMed
Search for other papers by D. J. A. Eckland in
Google Scholar
PubMed
Search for other papers by O. J. F. Foster in
Google Scholar
PubMed
Search for other papers by S. L. Lightman in
Google Scholar
PubMed
ABSTRACT
Propylthiouracil (PTU) was administered to rats for different lengths of time with or without food deprivation on the last 2 days. Within 4 days of PTU treatment peripheral 3,5,3′-tri-iodothyronine (T3) fell to low levels and β-subunit of thyroid-stimulating hormnone (β-TSH) mRNA increased significantly in the anterior pituitary. Pro-thyrotrophin-releasing hormone (pro-TRH) mRNA in the hypothalamic paraventricular nucleus (PVN) increased significantly in the control group of animals by 8 days and in the food-deprived group by day 12; the increment of pro-TRH mRNA in the food-deprived group on day 12 was significantly less than that in the control group. In a second study, animals were treated with intraperitoneal injections of T3 with or without the food deprivation. After 4 days of T3 treatment, peripheral T3 levels were markedly increased and pro-TRH mRNA in the PVN and β-TSH mRNA in the anterior pituitary were significantly reduced. Food deprivation had no additional suppressive effect. These studies confirm that the predominant effect of food deprivation on the thyroid axis is at the hypothalamic or suprahypothalamic level and that it can, at least in part, overcome the increase in TRH mRNA due to diminished T3 feedback.
Journal of Endocrinology (1992) 133, 183–188
Search for other papers by T P Fletcher in
Google Scholar
PubMed
Search for other papers by I J Clarke in
Google Scholar
PubMed
Abstract
This study examined the effect of thyroidectomy (TX) on the GH axis in sheep. The secretion of GH was monitored 10 and 77 days after TX or sham-TX when the effects on plasma GH and prolactin levels of the injection of 0·5 μg GH-releasing factor (GRF)/kg and 1 μg thyrotrophin-releasing hormone (TRH)/kg were also assessed.
There were no significant differences in GH pulse amplitude, pulse frequency, inter-pulse interval and GH secreted/h between sham-TX and TX animals at 10 or 77 days after TX.
There was no difference in the GH response to GRF injection in sham-TX sheep at any time but in TX sheep the GH response was significantly (P<0·05) attenuated 10 days after TX. After 77 days the GH response was similar to the response before TX. There was no measurable GH response to injection of TRH in sham-operated or TX sheep at any time. The prolactin response to TRH was not affected by TX or sham-TX.
These results suggest that TX in sheep does not affect GH secretion but paradoxically the response to GRF is attenuated in hypothyroid sheep in the short term. TRH causes release of prolactin but not GH in sheep.
Journal of Endocrinology (1994) 140, 495–502
Search for other papers by C. D. Ingram in
Google Scholar
PubMed
Search for other papers by R. J. Bicknell in
Google Scholar
PubMed
ABSTRACT
Synthetic human pancreatic GH-releasing factor (1–44)NH2 (GRF) and acetylcholine (ACh) were shown to evoke a dose-related release of GH from cultured bovine pituitary cells with half-maximal effective doses of 0·3 and 500 nmol/l respectively. Concentrations of ACh (10 μmol/l) and GRF (25 nmol/l) which were shown to give near maximal responses when presented alone, produced highly synergistic responses when tested in combination. This synergism was related to the ACh concentration employed, and both the ACh-induced release and ACh-induced synergism were abolished by the muscarinic antagonist, atropine. A synergistic interaction was also demonstrated between GRF and concentrations of thyrotrophin-releasing hormone (TRH) and bombesin which, in the absence of GRF, failed to elicit significant GH release. Acetylcholine stimulated a similar dose-dependent release of prolactin, but GRF was ineffectual in either directly stimulating prolactin release or affecting the response to ACh or TRH. No synergistic interaction could be detected between combinations of ACh and TRH or between ACh and bombesin. The data suggest that, in the somatotroph, GRF acts through a different second messenger pathway to ACh, TRH and bombesin and that these two pathways can be activated to produce a potentiated response. Growth hormone-releasing factor is, therefore, not only a specific GH secretagogue, but may act in concert with other hypophysiotrophic factors to regulate GH secretion from the bovine anterior pituitary.
J. Endocr. (1986) 109, 67–74
